Further study into the synergistic effect of insulin and IGF-1 to investigate IGF-1 response in hyperinsulinemia conditions can help understand the correlation between metabolic dysregulation and the IGF axis in cancer progression. The gene discussed is INS; the disease is hyperinsulinism.